IBDEI20K ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34163,1,4,0)
 ;;=4^Z91.128
 ;;^UTILITY(U,$J,358.3,34163,2)
 ;;=^5063613
 ;;^UTILITY(U,$J,358.3,34164,0)
 ;;=Z77.120^^131^1681^67
 ;;^UTILITY(U,$J,358.3,34164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34164,1,3,0)
 ;;=3^Mold (Toxic) Contact/Exposure
 ;;^UTILITY(U,$J,358.3,34164,1,4,0)
 ;;=4^Z77.120
 ;;^UTILITY(U,$J,358.3,34164,2)
 ;;=^5063318
 ;;^UTILITY(U,$J,358.3,34165,0)
 ;;=Z86.74^^131^1681^110
 ;;^UTILITY(U,$J,358.3,34165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34165,1,3,0)
 ;;=3^Personal Hx of Sudden Cardiac Arrest 
 ;;^UTILITY(U,$J,358.3,34165,1,4,0)
 ;;=4^Z86.74
 ;;^UTILITY(U,$J,358.3,34165,2)
 ;;=^5063478
 ;;^UTILITY(U,$J,358.3,34166,0)
 ;;=Z86.718^^131^1681^117
 ;;^UTILITY(U,$J,358.3,34166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34166,1,3,0)
 ;;=3^Personal Hx of Venous Thrombosis/Embolism (DVT)
 ;;^UTILITY(U,$J,358.3,34166,1,4,0)
 ;;=4^Z86.718
 ;;^UTILITY(U,$J,358.3,34166,2)
 ;;=^5063475
 ;;^UTILITY(U,$J,358.3,34167,0)
 ;;=Z96.1^^131^1681^127
 ;;^UTILITY(U,$J,358.3,34167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34167,1,3,0)
 ;;=3^Presence of Intraocular Lens
 ;;^UTILITY(U,$J,358.3,34167,1,4,0)
 ;;=4^Z96.1
 ;;^UTILITY(U,$J,358.3,34167,2)
 ;;=^5063682
 ;;^UTILITY(U,$J,358.3,34168,0)
 ;;=Z96.612^^131^1681^132
 ;;^UTILITY(U,$J,358.3,34168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34168,1,3,0)
 ;;=3^Presence of Left Artificial Shoulder Joint
 ;;^UTILITY(U,$J,358.3,34168,1,4,0)
 ;;=4^Z96.612
 ;;^UTILITY(U,$J,358.3,34168,2)
 ;;=^5063693
 ;;^UTILITY(U,$J,358.3,34169,0)
 ;;=Z96.611^^131^1681^137
 ;;^UTILITY(U,$J,358.3,34169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34169,1,3,0)
 ;;=3^Presence of Right Artificial Shoulder Joint
 ;;^UTILITY(U,$J,358.3,34169,1,4,0)
 ;;=4^Z96.611
 ;;^UTILITY(U,$J,358.3,34169,2)
 ;;=^5063692
 ;;^UTILITY(U,$J,358.3,34170,0)
 ;;=Z93.0^^131^1681^145
 ;;^UTILITY(U,$J,358.3,34170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34170,1,3,0)
 ;;=3^Tracheostomy Status
 ;;^UTILITY(U,$J,358.3,34170,1,4,0)
 ;;=4^Z93.0
 ;;^UTILITY(U,$J,358.3,34170,2)
 ;;=^5063642
 ;;^UTILITY(U,$J,358.3,34171,0)
 ;;=Z99.3^^131^1681^149
 ;;^UTILITY(U,$J,358.3,34171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34171,1,3,0)
 ;;=3^Wheelchair Dependence
 ;;^UTILITY(U,$J,358.3,34171,1,4,0)
 ;;=4^Z99.3
 ;;^UTILITY(U,$J,358.3,34171,2)
 ;;=^5063759
 ;;^UTILITY(U,$J,358.3,34172,0)
 ;;=A15.0^^131^1682^84
 ;;^UTILITY(U,$J,358.3,34172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34172,1,3,0)
 ;;=3^Tuberculosis of Lung
 ;;^UTILITY(U,$J,358.3,34172,1,4,0)
 ;;=4^A15.0
 ;;^UTILITY(U,$J,358.3,34172,2)
 ;;=^5000062
 ;;^UTILITY(U,$J,358.3,34173,0)
 ;;=B20.^^131^1682^31
 ;;^UTILITY(U,$J,358.3,34173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34173,1,3,0)
 ;;=3^HIV Disease
 ;;^UTILITY(U,$J,358.3,34173,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,34173,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,34174,0)
 ;;=B02.9^^131^1682^93
 ;;^UTILITY(U,$J,358.3,34174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34174,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,34174,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,34174,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,34175,0)
 ;;=A60.9^^131^1682^2
 ;;^UTILITY(U,$J,358.3,34175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34175,1,3,0)
 ;;=3^Anogenital Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,34175,1,4,0)
 ;;=4^A60.9
 ;;^UTILITY(U,$J,358.3,34175,2)
 ;;=^5000359
 ;;^UTILITY(U,$J,358.3,34176,0)
 ;;=A60.04^^131^1682^34
 ;;^UTILITY(U,$J,358.3,34176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34176,1,3,0)
 ;;=3^Herpesviral Vulvovaginitis
